Mucinous cystadenocarcinoma historical perspective
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma historical perspective |
|
Mucinous cystadenocarcinoma historical perspective in the news |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
In 1886, few pathologists in Chicago conducting experiments on mice to fond out the role of PTEN mutation in cancer development found an association between PTEN mutation with the development of mucinous cystadenocarcinoma. Mucinous cystadenocarcinoma of the renal pelvis was first described as a separate entity in 1960 by Hasebe et al.
Discovery
- In 1886, T DeJulio and other pathologists studying the development of colitis-induced mucinous carcinoma described the association of PTEN mutation with the development of invasive mucinous cystadenocarcinoma.[1]
- Mucinous cystadenocarcinoma of the renal pelvis was first described in 1960 by Hasebe et al.[2]
- Cystic lesions of the pancreas were first described by Becourt in 1824.
References
- ↑ "www.nature.com" (PDF).
- ↑ HASEBE M, SERIZAWA S, CHINO S (1960). "[On a case of papillary cystadenocarcinoma following malignant degeneration of a papillary adenoma in the kidney pelvis]". Yokohama Med Bull. 11: 491–500. PMID 13712095.